Christopher Evans

Redefining the boundaries of what is possible in the field of urology, Christopher P. Evans serves as a Professor of Urology at the University of California, Davis. With a keen focus on the intricate mechanisms of prostate cancer, Dr. Evans is at the forefront of research exploring the regulation of prostate cancer cells, particularly through the lens of neurotrophins and tyrosine kinases. His work is pivotal in understanding the complex pathways that contribute to the progression and treatment of prostate cancer. Dr. Evans is currently the Principal Investigator for two significant research projects funded by the NIH/NIDDK and the Biomedical Research Program. These projects delve into the regulation of the urokinase gene and neuroendocrine differentiation in prostate cancer, aiming to uncover novel therapeutic targets and improve patient outcomes. His dedication to advancing the field is evident in his extensive publication record, which includes numerous articles in esteemed peer-reviewed journals. Among his notable contributions is a recent article in European Urology Focus, which examines the incidence of secondary bladder cancer following prostate cancer treatment. This work highlights the potential long-term effects of prostate cancer therapies and underscores the importance of comprehensive patient care. Dr. Evans's research interests extend beyond the laboratory, as he actively collaborates with fellow researchers and clinicians to translate his findings into clinical practice. His commitment to innovation and excellence in urology continues to inspire both his peers and the next generation of medical professionals.